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INTRODUCTION:  AML is  the  most  common  form  of leukemia  in  adults.  In rare  circumstances  AML  may
present  in  the  form  of  extra-medullary  disease.  Gallbladder  inﬁltration  with  myeloblasts  is rare  and  only
a  few  cases  exist  in  the  literature  describing  this  entity.
PRESENTATION OF  CASE:  We present  a rare  case  of AML  relapse  in  the  form  of  extramedullary  inﬁltration
of  the  gallbladder  in  a 50-year-old  male  patient.  The  leukemic  inﬁltration  presented  as  symptomatic
cholecystitis  and  sepsis.  A laparoscopic  cholecystectomy  was  performed  and  the  gallbladder  was  patho-
logically  examined.  Histopathologic  examination  demonstrated  multiple  scattered,  highly  atypical  single
cells  admixed  with  some  plasma  cells,  small  lymphocytes  and  macrophages  consistent  with  leukemic
inﬁltration.  The  abnormal  cells  demonstrated  immunohistochemical  staining  for CD68, CD33  and  CD117.
The  patient  did  well  post-operatively  but  the relapse  precluded  him  from  bone  marrow  transplantation.
DISCUSSION:  Although  AML  is  relatively  common,  3  cases  per 100,000  population,  extramedullary  disease
in  the  form  of gallbladder  inﬁltration  is exceedingly  rare.  An extensive  review  of the  literature  revealed
only  four  cases  of myeloid  inﬁltration  of the  gallbladder.  To  our  knowledge  this  is  the  only  case  of  relapsing
disease  in the  form  of  gallbladder  inﬁltration  presenting  as  symptomatic  cholecystitis  in a  pre-bone
marrow  transplantation  patient.
CONCLUSION: This  case  highlights  the  importance  of  maintaining  a high  index  of suspicion  of  atypical
manifestations  of  AML  when  managing  refractory  sepsis.  Extramedullary  manifestations  of AML  in  the
form  of  gallbladder  inﬁltration  must  be considered  in  the  differential  diagnosis  of patients  with  a  history
of  myeloid  malignancies  and  for patients  whom  fail  conventional  non-operative  management.
©  2014  The  Authors.  Published  by Elsevier  Ltd. on  behalf  of Surgical  Associates  Ltd.  . Introduction
Acute myeloid leukemia is a hematological malignancy char-
cterized by a variable clinical course. Patients diagnosed with
cute leukemia may  present with myeloid sarcoma, leukemic
nﬁltration of the gastrointestinal tract or mediastinum, and in
are circumstances, inﬁltration of the biliary system with myeloid
ells. We  report a case of a patient who presented with acute
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ttp://dx.doi.org/10.1016/j.ijscr.2014.02.003
210-2612 © 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Acholecystitis as a manifestation of his acute myeloid leukemia
through inﬁltration of the gallbladder wall with immature myeloid
lineage cells.
2.  Case
A 50-year-old male receiving care at our institution for acute
myeloid leukemia (AML) in his second morphological free state,
presented to the Emergency Department with worsening diarrhea,
intermittent nausea and vomiting, fever, right upper quadrant pain,
and decreased oral intake in the setting of a 2-month history of
chronic cholecystitis. Initial laboratory investigations revealed pan-
Open access under CC BY-NC-ND license.cytopenia (hemoglobin 98 g/L [120–160 g/L], platelets 17 × 109/L
[150–400 × 109/L], WBC  1.1 × 109/L [4.0–11.0 × 109/L] with 0%
blasts), and an elevated alkaline phosphatase (ALP) of 218 U/L
[40–150 U/L] with a total bilirubin of 28 mol/L [≤22 mol/L].
ssociates Ltd. Open access under CC BY-NC-ND license.
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Fig. 2. (a) Hematoxylin–Eosin stained section from gallbladder wall showing dif-
fuse inﬁltrates of mononuclear cells with irregular nuclei and some with prominent
nucleoli.  Scattered lymphocytes, plasma cells and macrophages are also present. (b)
CD117, however, CD34 was not increased (Fig. 2b and c). Theseig. 1. Computed axial tomography (CAT) demonstrating thickening of the gallblad-
er with surrounding edema and inﬂammation.
He was initially diagnosed with AML  in May  2012, which had
ransformed from chronic myelogenous leukemia (CML) with nor-
al  cytogenetics. As a result, he was started on induction therapy
ith standard-dose Cytarabine and Idarubicin and achieved a mor-
hological free state by June 2012. Unfortunately, in November
012, he was found to have a relapse of his AML  that was  con-
rmed by bone marrow biopsy (10–12% blasts), peripheral blood
mear (5–6% blasts), ﬂow cytometry and an elevated LDH of 638 U/L
125–220 U/L]. As a result, he underwent re-induction therapy with
OVE-HiDAC (Mitoxantrone, Etoposide and high-dose Cytarabine)
n December 2012, and once again achieved a morphological free
tate without count recovery. He was subsequently accepted for
llogenic bone-marrow transplant, with a tentative date of June
013.
While awaiting a matched donor for bone-marrow transplan-
ation, he was admitted for cholecystitis and febrile neutropenia,
he former of which was managed conservatively with broad-
pectrum intravenous antibiotics (Piperacillin-Tazobactam) given
is thrombocytopenia and perioperative risk proﬁle. Six days
ollowing discharge, he was readmitted with increasing nausea,
omiting, fever, and RUQ pain. In addition to a second course of
ntibiotics (Vancomycin, Colistin, Flagyl and Voriconazole), a per-
utaneous cholecystostomy tube was also placed for source control.
omputerized axial tomography (CAT) of the abdomen was per-
ormed and demonstrated gallbladder distension and thickening
onsistent with cholecystitis. However, there was  no evidence of
eri-cholecystic ﬂuid or associated inﬂammatory changes around
he gallbladder. Dilation of intrahepatic ducts and common bile
uct were not seen (Fig. 1). He was discharged home with improve-
ents in his abdominal pain and oral intake; however, soon after
ischarge, he had a relapse of his cholecystitis-related symptoms
nd was once again managed conservatively and re-admitted to
ospital. A percutaneous contrast study evaluating drain placement
as performed and demonstrated persistent obstruction of the cys-
ic duct. For these reasons, the cholecystostomy tube was  left in
itu.
Approximately 7 weeks after his initial presentation, surgical
onsultation was sought in order to determine his eligibility to
ndergo an elective cholecystectomy for deﬁnitive source control, a
rerequisite for bone-marrow transplantation. Although deﬁnitive
urgical management was ultimately delayed secondary to subse-
uent hospital admissions for febrile neutropenia and cholecystitis,
e eventually underwent laparoscopic cholecystectomy approxi-
ately 3 months following his initial presentation.The majority of cells stain positive for CD68 KP-1 epitope, which is positive not only
in macrophages but also in myeloid and monocytic precursors.8 (c) Only rare cells
stained positive for CD68-R PGM-1 epitope, which is more macrophage speciﬁc.9
Intra-operatively, there were extensive adhesions in the right
upper quadrant. During the dissection, the gallbladder was entered
with subsequent extrusion of purulent and necrotic debris. Overall,
the patient tolerated the procedure well and there were no intra-
operative complications. Macroscopically the resected gallbladder
showed a tan colored ﬁbrinous exudate and a completely necrotic
back wall. Histopathologic examination of the specimen demon-
strated multiple scattered, highly atypical single cells admixed with
some plasma cells, small lymphocytes and macrophages consistent
with leukemic inﬁltration (Fig. 2a). The abnormal cells demon-
strated immunohistochemical staining for CD68 (KP1), CD33 andﬁndings were consistent with the manifestation of his previously
known myelomonocytic leukemia, and the second relapse of his
disease. A peripheral blood smear and bone-marrow aspirate and
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Table 1
Literature review summary of myeloid inﬁltration of gallbladder.
Age/sex Malignancy status
prior  to presentation
Presentation Surgical approach BMBa or PBSb
Shimizu et al. (2006) 59,  M MDS  Cholecystitis Open cholecystectomy AML
Bartley  et al. (2006) 63, F None Back pain Open cholecystectomy Negative
Ojima  et al. (2005) 33, M None Jaundice Hepatopancreato-duodenectomy Negative
Bloom  et al. (2002) 49, M None Cholecystitis Open cholecystectomy AML
Current  case 50, M AML  in remission Cholecystitis Laparoscopic cholecystectomy AML  relapse
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approved the ﬁnal version of the manuscript.a BMB – bone marrow biopsy.
b PBS – peripheral blood smear.
iopsy were conducted. While the peripheral blood ﬁlm demon-
trated pancytopenia and polychromasia, the bone marrow biopsy
as consistent with hypercellularity and granulocytic hyperplasia.
low cytometry analysis showed 15% of cells in the lymphocyte
egion, 5% in the monocyte region, and 30% in the region for
ranulopoiesis. CD34+ cells comprised approximately 2.5% of bone
arrow cells and were positive for CD117, CD13 and variably for
D33. Furthermore, the CD34+ cells showed aberrant phenotype
ith decreased CD45 expression and positivity for CD7 suggesting
resence of the residual disease in the bone marrow.
Collectively, these ﬁndings suggested extramedullary relapse
f the patient’s known AML  despite two cycles of induction ther-
py. The presence of disease activity precluded him from receiving
one-marrow transplantation due to the risk associated with addi-
ional systemic chemotherapy. The patient agreed that he would
ikely not be able to tolerate further chemotherapy and the goal
f care was shifted to best supportive care. At the time of last
linic visit (5 months following surgery) the patient had no further
holecystitis-like symptoms but continues to be seen weekly at our
nstitution’s transfusion clinic for management of his pancytopenia.
. Discussion
In adults, AML  is the most common form of acute leukemia, with
n incidence of approximately 3 cases per 100,000 population.1
ML  is characterized by clonal proliferation of immature myeloid
ells that aggressively take over the bone marrow and suppress
ormal hematopoiesis. As a result, patients present clinically
ith symptoms related to pancytopenia (fatigue, fever, petechiae,
tc.), organomegaly (secondary to extramedullary hematopoiesis)
nd/or bone pain. In rare circumstances (<1% of cases), AML  may
resent as extramedullary disease in the form of a myeloid sarcoma
nvolving the skull, skin, lymph nodes, or axial skeleton or it may
nvolve the gastrointestinal tract, orbit, and/or mediastinum.2,3
allbladder inﬁltration with myeloblasts, however, is exceptionally
are and only a few case reports exist in the literature describing
his clinical entity.4–7
This case illustrates the relapse of acute myeloid leukemia (AML)
n the form of gallbladder wall inﬁltration, causing symptomatic
holecystitis, and the ﬁrst case to our knowledge of AML relapse
n the form of symptomatic gallbladder inﬁltration in a patient
waiting bone marrow transplant.
A comprehensive search strategy was devised with experienced
nformation specialists at the University Health Network Library.
 combination of medical subject heading (MeSH) terms and rel-
vant text words related to leukemia and gallbladder pathology
ere utilized. Ovid MEDLINE and Ovid Embase were searched for
elevant citations between 1946 and 2013. No language restriction
as applied. The title and abstract of the total yield of citations were
creened for potential eligibility. The abstract and/or full texts of
he potentially eligible citations were obtained for further review,
nd those that did not meet the selection criteria were excluded.
ltimately, the search yielded only four relevant case reports of
yeloid cell leukemic involvement in the gallbladder (Table 1).Three cases corresponded to myeloid inﬁltration of the gallblad-
der as the primary manifestation of disease without involvement
of the bone marrow,4–6 whereas one occurred in the setting of
myelodysplastic syndrome with progression to acute leukemia.7
Although cholecystitis was diagnosed in each of these patients,
the underlying etiology and clinical presentation differed quite
signiﬁcantly. In one case, the patient presented with widespread
extra-medullary myeloid sarcoma and incidental gallbladder
involvement,4 while in another case, the patient presented with
jaundice and was  found to have a gallbladder mass.5
This case highlights the importance of maintaining a high index
of suspicion of atypical manifestations of AML  when managing
refractory sepsis. In this particular example, the persistent symp-
toms associated with acute cholecystitis continued in spite of
parenteral antibiotics and biliary decompression. Failure of con-
ventional non-operative management was an indication that the
etiology of this disease was related to gallbladder leukemic inﬁltra-
tion rather than gallstones alone. Early recognition of the patient’s
AML may  have resulted in a change in management with aggres-
sive, early surgical intervention. While the patient’s candidacy for
bone marrow transplantation may  not have changed, early diag-
nosis may  have improved patient counseling and streamlined the
patient care journey.
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Key learning points
• Extramedullary  relapse of AML  in the form of gallbladder inﬁltration is rare.
• Gallbladder  inﬁltration with myeloblasts should be considered in the differential for cholecystitis.
• Clinicians must maintain a high-index of suspicion of atypical manifestations of AML  when managing refractory sepsis.
• Patients with a known history of AML  whom present with cholecystitis refractory to medical management may beneﬁt
from earlier surgical intervention.
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